Clinical Trial Update: Protocol for Radiofrequency Ablation of Pulmonary Neoplasms [NA]

View source ↗

Summary

A clinical trial protocol investigating radiofrequency ablation for pulmonary neoplasms has been terminated; sponsor is Oncology Specialties in Alabama.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Oncology Specialties, Alabama | Conditions: Pulmonary Neoplasms | NA | Status: TERMINATED